PGY-1 @ Rochester Gen Hospital via @MethodistHosp @Almallah_Labs via @AinshamsMed 🇪🇬 | #cardiology🫀 #R💻 #football⚽️|Tweets My Own.
Houston, Texas
Joined June 2013
- Tweets965
- Following1K
- Followers444
- Likes3.8K
Ahmed Sayed retweeted
jacc.org/doi/10.1016/j.jacc.… Confirming and quantifying what was suspected - heart failure is evolving. Significant evidence generation implications.
Ahmed Sayed retweeted
Original Article: Beta-blockers after Myocardial Infarction with Normal Ejection Fraction nej.md/43U5Ppo
@AHAScience | #AHA25
ALT Kaplan–Meier curves for the primary end point and its components.
ALT Treatment estimates and sensitivity analyses.
ALT Prespecified subgroup analyses of the primary end point.
How does the move to PREVENT for ASCVD risk estimation affect aspirin use❓
📜jamanetwork.com/journals/jam…
1⃣ >80% eligible for 1ry prevention aspirin based on a PCE risk >10% would no longer be eligible w/ PREVENT
2⃣ Most current aspirin users don't qualify under either calculator
🙏🙏Immensely grateful for the generous support and guidance from Dr. Ann Marie Navar, @virani_md, @ericpetersonMD, and @dramitkhera 🙏🙏
And many thanks to @JAMAInternalMed for offering an avenue to share our findings
Ahmed Sayed retweeted
Biggest move today in clinic:
Stopping ASA in pts on DOAC
AQUATIC = most important trial of the year.
medscape.com/viewarticle/aqu…
Ahmed Sayed retweeted
Here are my takeaways for the 7 most relevant and important #ESCCongress2025 for generalists
AQUATIC, HI-PRO, RETREAT-FRAIL, DIGIT-HF, DAN-RSV were most practicing changing
POTCAST was most contentious - not as billed
Do heart transplant patients always need invasive angio to screen for graft vasculopathy❓
📜authors.elsevier.com/a/1lWfA…
In this meta-analysis, CTA/PET had pretty respectable sensitivity/NPV for ruling out graft vasculopathy compared to a gold standard of invasive angiography.
🙏Incredibly grateful to @almallahmo for supervision , @MalekNayfeh, Fares AlAhdab, Mahmoud Al Rifai, @DmitryAbramovMD, @FudimMarat , @YasMoayedi, @RayanYousefzai for their incredible support, and to @JACCJournals CV imaging for the opportunity to publish our work🙏
Ahmed Sayed retweeted
NEW PAPER in @bmj_latest "Dealing with continuous variables and modelling non-linear associations in healthcare data: practical guide"
--> bmj.com/content/390/bmj-2024…
#methodologymatters
Ahmed Sayed retweeted
Over the past 41 years, death due to ischemic heart disease did not decline in countries with low socioeconomic development, research shows @ASayedMD @MethodistHosp @virani_md @ErinMichos @annmarienavar @DrLaPrincess ahajrnls.org/3EWOnYl
1/4🧵
In patients undergoing cardiac stress testing w/ PET, does rest flow matter❓
In an analysis of >8k patients, we find that it does, esp. in patients with a preserved EF.
Link📜: doi.org/10.1093/ehjci/jeaf13…
@almallahmo @MariaAlwan_ @MyASNC @MethodistHosp @EHJCVIEiC
Patients with a normal-ish EF could be further stratified as being at a *truly* low-risk of events or at intermediate risk depending on their rest flow.
In contrast, patients with a depressed EF had a uniformly high rate of events regardless.
🙏🙏Incredibly thankful to @almallahmo and Dr. Al Rifai for their supervision & guidance on this; and to my brilliant colleague @MariaAlwan_ 🙏🙏
And thank you to @EHJCVIEiC for allowing us to share our findings!
Ahmed Sayed retweeted
𝐃𝐒𝐄 𝐝𝐞𝐥𝐢𝐯𝐞𝐫𝐬 𝐢𝐧 𝐎𝐑𝐁𝐈𝐓𝐀-𝟐: Stress echo ischemia identifies who 𝘳𝘦𝘢𝘭𝘭𝘺 benefits from PCI. 📖 𝐉𝐮𝐬𝐭 𝐩𝐮𝐛𝐥𝐢𝐬𝐡𝐞𝐝 𝐢𝐧 #𝐉𝐀𝐂𝐂: bit.ly/42PNCcB
@rallamee @mshunshin @rajkumar_chris @MikeFoley89 @FloSimader @ShaynaChotai
Ahmed Sayed retweeted
An incredible experience at #DDW2025! Privileged to share our work on #pancreaticcancer, Fatty Pancreas, and #colorectalcancer
With 3 oral presentations, and 3 poster presentations ✅
Immensely grateful for the mentorship and support of Dr. @SriGaddamMD 🙏🏼
Ahmed Sayed retweeted
New genetic analysis in 200k people over 14 years
▶️apoB + lp(a) best capture lipid-mediated CV risk
▶️LDL particle size adds no additional info when apoB is accounted for
academic.oup.com/eurheartj/a…
Ahmed Sayed retweeted
Intensive LDL-C lowering with Evolocumab may lead to greater relative reduction in cardiovascular events in patients with autoimmune or inflammatory diseases. @AndreZimerman @bweber04 @analaurakunzler
@rgiuglaino ahajournals.org/doi/full/10.…
Ahmed Sayed retweeted
Just in time for #HRS2025‼️
Excited to share our latest paper published in @AmericanHeartJ and honored to be first co-author with Dr. Bockus.
Looking forward to presenting our work in San Diego.
sciencedirect.com/science/ar…
@NazemAkoum @UWMedHeart
